Volodymyr G. Bdzhola - Search Results

Year	Number of Results
2006	1
2008	1
2011	4
2012	3
2013	5
2014	4
2015	3
2016	4
2017	1
2019	3
2020	1
2021	1
2022	3
2023	1
2024	0

1

Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors.

Starosyla SA, Volynets GP, Protopopov MV, Bdzhola VG, Pashevin DO, Polishchuk VO, Kozak TO, Stroi DO, Dosenko VE, Yarmoluk SM. Starosyla SA, et al. Among authors: bdzhola vg. Struct Chem. 2023;34(3):1157-1171. doi: 10.1007/s11224-022-02075-y. Epub 2022 Oct 11. Struct Chem. 2023. PMID: 36248344 Free PMC article.

2

Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning.

Volynets GP, Usenko MO, Gudzera OI, Starosyla SA, Balanda AO, Syniugin AR, Gorbatiuk OB, Prykhod'ko AO, Bdzhola VG, Yarmoluk SM, Tukalo MA. Volynets GP, et al. Among authors: bdzhola vg. Future Med Chem. 2022 Sep;14(17):1223-1237. doi: 10.4155/fmc-2022-0085. Epub 2022 Jul 25. Future Med Chem. 2022. PMID: 35876255

3

Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening.

Volynets GP, Barthels F, Hammerschmidt SJ, Moshynets OV, Lukashov SS, Starosyla SA, Vyshniakova HV, Iungin OS, Bdzhola VG, Prykhod'ko AO, Syniugin AR, Sapelkin VM, Yarmoluk SM, Schirmeister T. Volynets GP, et al. Among authors: bdzhola vg. J Antibiot (Tokyo). 2022 Jun;75(6):321-332. doi: 10.1038/s41429-022-00524-8. Epub 2022 Apr 19. J Antibiot (Tokyo). 2022. PMID: 35440771 Free PMC article.

4

Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.

Rybak MY, Balanda AO, Yatsyshyna AP, Kotey IM, Starosyla SA, Bdzhola VG, Lukash LL, Yarmoluk SM, Tukalo MA, Volynets GP. Rybak MY, et al. Among authors: bdzhola vg. Sci Rep. 2021 Mar 30;11(1):7162. doi: 10.1038/s41598-021-86562-y. Sci Rep. 2021. PMID: 33785838 Free PMC article.

5

Novel isoniazid derivative as promising antituberculosis agent.

Volynets GP, Tukalo MA, Bdzhola VG, Derkach NM, Gumeniuk MI, Tarnavskiy SS, Yarmoluk SM. Volynets GP, et al. Among authors: bdzhola vg. Future Microbiol. 2020 Jul;15(10):869-879. doi: 10.2217/fmb-2019-0085. Epub 2020 Jul 14. Future Microbiol. 2020. PMID: 32662670 Free PMC article.

6

Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines.

Kovalenko OP, Volynets GP, Rybak MY, Starosyla SA, Gudzera OI, Lukashov SS, Bdzhola VG, Yarmoluk SM, Boshoff HI, Tukalo MA. Kovalenko OP, et al. Among authors: bdzhola vg. Medchemcomm. 2019 Nov 28;10(12):2161-2169. doi: 10.1039/c9md00347a. eCollection 2019 Dec 1. Medchemcomm. 2019. PMID: 32206244 Free PMC article.

7

Dual-targeted hit identification using pharmacophore screening.

Volynets GP, Starosyla SA, Rybak MY, Bdzhola VG, Kovalenko OP, Vdovin VS, Yarmoluk SM, Tukalo MA. Volynets GP, et al. Among authors: bdzhola vg. J Comput Aided Mol Des. 2019 Nov;33(11):955-964. doi: 10.1007/s10822-019-00245-5. Epub 2019 Nov 6. J Comput Aided Mol Des. 2019. PMID: 31691918

8

Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis.

Volynets GP, Tukalo MA, Bdzhola VG, Derkach NM, Gumeniuk MI, Tarnavskiy SS, Starosyla SA, Yarmoluk SM. Volynets GP, et al. Among authors: bdzhola vg. J Antibiot (Tokyo). 2019 Apr;72(4):218-224. doi: 10.1038/s41429-019-0140-9. Epub 2019 Jan 21. J Antibiot (Tokyo). 2019. PMID: 30662064

9

Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor.

Niefind K, Bischoff N, Golub AG, Bdzhola VG, Balanda AO, Prykhod'ko AO, Yarmoluk SM. Niefind K, et al. Among authors: bdzhola vg. Pharmaceuticals (Basel). 2017 Jan 11;10(1):9. doi: 10.3390/ph10010009. Pharmaceuticals (Basel). 2017. PMID: 28085026 Free PMC article.

10

Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2.

Syniugin AR, Ostrynska OV, Chekanov MO, Volynets GP, Starosyla SA, Bdzhola VG, Yarmoluk SM. Syniugin AR, et al. Among authors: bdzhola vg. J Enzyme Inhib Med Chem. 2016;31(sup4):160-169. doi: 10.1080/14756366.2016.1222584. Epub 2016 Sep 2. J Enzyme Inhib Med Chem. 2016. PMID: 27590574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year